CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance

Radiotherapy is a mainstay for treatment of many human cancer types, including head and neck squamous cell carcinoma (HNSCC). Thereby, it is clinically very relevant to understand the mechanisms determining radioresistance. Here, we identify CIP2A as an Oct4 target gene and provide evidence that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventelä, Sami, Sittig, Eleonora, Mannermaa, Leni, Mäkelä, Juho-Antti, Kulmala, Jarmo, Löyttyniemi, Eliisa, Strauss, Leena, Cárpen, Olli, Toppari, Jorma, Grénman, Reidar, Westermarck, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381584/
https://www.ncbi.nlm.nih.gov/pubmed/25474139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381584/
https://www.ncbi.nlm.nih.gov/pubmed/25474139

Ejemplares similares